DE3586580D1 - Zur wirksamen gen-expression faehiger vektor und verwendung desselben. - Google Patents

Zur wirksamen gen-expression faehiger vektor und verwendung desselben.

Info

Publication number
DE3586580D1
DE3586580D1 DE8585115146T DE3586580T DE3586580D1 DE 3586580 D1 DE3586580 D1 DE 3586580D1 DE 8585115146 T DE8585115146 T DE 8585115146T DE 3586580 T DE3586580 T DE 3586580T DE 3586580 D1 DE3586580 D1 DE 3586580D1
Authority
DE
Germany
Prior art keywords
vector
gene expression
polypeptide
protein
base sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8585115146T
Other languages
English (en)
Other versions
DE3586580T2 (de
Inventor
Takehiro Oshima
Shoji Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asubio Pharma Co Ltd
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of DE3586580D1 publication Critical patent/DE3586580D1/de
Publication of DE3586580T2 publication Critical patent/DE3586580T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
DE8585115146T 1984-11-30 1985-11-29 Zur wirksamen gen-expression faehiger vektor und verwendung desselben. Expired - Lifetime DE3586580T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59253423A JP2594535B2 (ja) 1984-11-30 1984-11-30 高発現ベクターおよびその利用

Publications (2)

Publication Number Publication Date
DE3586580D1 true DE3586580D1 (de) 1992-10-08
DE3586580T2 DE3586580T2 (de) 1993-03-18

Family

ID=17251184

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585115146T Expired - Lifetime DE3586580T2 (de) 1984-11-30 1985-11-29 Zur wirksamen gen-expression faehiger vektor und verwendung desselben.

Country Status (5)

Country Link
EP (1) EP0183272B1 (de)
JP (1) JP2594535B2 (de)
AT (1) ATE80181T1 (de)
CA (1) CA1283069C (de)
DE (1) DE3586580T2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4798791A (en) * 1984-11-16 1989-01-17 Genex Corporation Vector for high level gene expression
US7976936B2 (en) 2002-10-11 2011-07-12 University Of Connecticut Endoprostheses
US7794494B2 (en) 2002-10-11 2010-09-14 Boston Scientific Scimed, Inc. Implantable medical devices

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ201705A (en) * 1981-08-31 1986-03-14 Genentech Inc Recombinant dna method for production of hepatitis b surface antigen in yeast
US4863855A (en) * 1982-05-14 1989-09-05 The Research Foundation Of State University Of New York Novel cloning vehicles for polypeptide expression in microbial hosts
EP0111814A3 (de) * 1982-12-16 1985-08-14 Mgi Pharma, Inc. Klonierung und Expression von nucleotiden Sequenzen die für Rinderwachstumshormon kodieren
WO1984004538A1 (en) * 1983-05-19 1984-11-22 Unilever Nv Improvements in the expression of newly introduced genes in yeast cells
US4710473A (en) * 1983-08-10 1987-12-01 Amgen, Inc. DNA plasmids
CA1340597C (en) * 1984-08-27 1999-06-22 Haim Aviv Expression vectors containing pl promoter, and engineered restriction site for convenient replacement of ribosomal binding site, plasmids containing the vectors, hosts containing the plasmids and related methods
US4798791A (en) * 1984-11-16 1989-01-17 Genex Corporation Vector for high level gene expression

Also Published As

Publication number Publication date
CA1283069C (en) 1991-04-16
EP0183272B1 (de) 1992-09-02
JP2594535B2 (ja) 1997-03-26
JPS61132186A (ja) 1986-06-19
DE3586580T2 (de) 1993-03-18
ATE80181T1 (de) 1992-09-15
EP0183272A2 (de) 1986-06-04
EP0183272A3 (en) 1988-01-20

Similar Documents

Publication Publication Date Title
DE3880739D1 (de) Expression von menschlichem proapolipoprotein a-1.
ATE284954T1 (de) Hyaluronan synthase gen und seine verwendung
ATE386101T1 (de) Expressionsplasmide, durch einen osmb promoter reguliert
PT80901B (pt) Processo para a preparacao de peptideos interfenona do tipo i codificados por novas sequencias geneticas
NO177570B (no) Fremgangsmåte ved fremstilling av peptider med fibronektinbindende egenskaper, mikroorganisme og DNA-sekvens som koder for peptider med fibronektinbindende egenskaper
PT83968A (de) Verfahren zur verbesserung des expression von eukaryontenprotein
DE3850774D1 (de) Rinder-interleukin-1-alpha.
NO930428D0 (no) Proteinstrukturen til plantetoksingelonin
DE3586580D1 (de) Zur wirksamen gen-expression faehiger vektor und verwendung desselben.
ATE109827T1 (de) Verfahren zur herstellung von peptiden, dazu zu verwendendes rekombinantes plasmid und mit diesem plasmid transformierte myelomzellen.
DE3850456D1 (de) Klonierung des isoamylaseenzym kodierenden Gens und seine Verwendung zur Herstellung dieses Enzyms.
KR910016923A (ko) 트롬빈 결합성 물질의 제조법
EP0422217A4 (en) Human recombinant placental ribonuclease inhibitor and method of production
AU650038B2 (en) CKS method of protein synthesis

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: DAICHI SUNTORY PHARMA CO., LTD., TOKIO/TOKYO, JP

8327 Change in the person/name/address of the patent owner

Owner name: DAIICHI ASUBIO PHARMA CO., LTD., TOKIO/TOKYO, JP